Personalized mRNA vaccines against pancreatic cancer have built up long-lasting killer T cells in a study. After 3.2 years, responders remained relapse-free significantly longer than non-responders.
Personalized mRNA vaccines against pancreatic cancer have built up long-lasting killer T cells in a study. After 3.2 years, responders remained relapse-free significantly longer than non-responders.
www.nature.com /articles/s41586-024-08508-4